Viewing StudyNCT00035178



Ignite Creation Date: 2024-05-05 @ 11:25 AM
Last Modification Date: 2024-10-26 @ 9:07 AM
Study NCT ID: NCT00035178
Status: COMPLETED
Last Update Posted: 2005-06-24
First Post: 2002-05-02

Brief Title: PharmacokineticsPharmacodynamics of Argatroban Injection in End-Stage Renal Disease Patients Undergoing Hemodialysis
Sponsor: Texas Biotechnology Corporation
Organization: Encysive Pharmaceuticals

Organization Data

Organization: Encysive Pharmaceuticals
Class: INDUSTRY
Study ID: ARG-402
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Texas Biotechnology Corporation
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators